Skip to content
healthcare.dev
Get a free key

Deferoxamine

NDC 63323-599, DEFEROXAMINE MESYLATE, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-599
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078718
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-599 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFEROXAMINE MESYLATE95 mg/mL

Pharmacologic classes

Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
63323-599-30633230599301 VIAL in 1 BOX (63323-599-30) / 21.1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d91e16df-8daa-4cd2-86a2-273eaa2446e0

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-599

Use it

Look up 63323-599 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-599 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-599. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.